Overexpression of miR-146a inhibits the proliferation and survival of breast, prostate, and pancreatic cancer cells through the downregulation of its targets including ROCK1, EGFR, and MTA-2 [55–58]. This evidence concerns the gene MTA2 and pancreatic neoplasm.